+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Acne Drugs Market (2021-2026) by Acne Type, Therapeutic Class, Drug Type, Drug Formulation, Distribution Channel, and Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis

  • PDF Icon


  • 181 Pages
  • November 2021
  • Region: Global
  • Infogence Global Research
  • ID: 5515451
The Global Acne Drugs Market is estimated to be USD 5.4 Bn in 2021 and is expected to reach USD 7.66 Bn by 2026, growing at a CAGR of 7.25%.

Market Dynamics

The growing unhealthy lifestyle coupled with increasing interest in facial aesthetics amongst individuals is the primary factor estimated to drive the growth of the Global Acne Drugs Market. In addition, the increasing awareness of acne treatment via social media advertisement and the development of generic drugs is boosting the market growth. However, side effects associated with acne drugs and stringent government regulations associated with the development and manufacturing of the drugs are expected to hinder the market growth during the forecast period.

Conversely, increasing R & D of effective medications with lesser side effects coupled with high market potential in untapped emerging economies are expected to provide lucrative growth opportunities for the market growth.

Market Segmentation

The Global Acne Drugs Market is segmented further based on Acne Type, Therapeutic Class, Drug Type, Drug Formulation, Distribution Channel, and Geography.

By Acne Type, the market is classified as Comedonal, Inflammatory, Cystic, and Postsurgical/Wound.

By Therapeutic Class, the market is classified as a Retinoid, Antibiotic, Hormonal Agent, Combination, and Others.

By Drug Type, the market is classified as OTC and Prescription Drugs.

By Drug Formulation, the market is classified as Topical Medications, Oral Medications, And Injectable.

By Distribution Channel, the market is segmented into Retail Store, Pharmacy & Drug Store, and E-Commerce.

By Geography, America is projected to lead the market.

Recent Developments

1. GlaxoSmithKline acquired Stiefel Laboratories, a reputed dermatology drug manufacturer, for USD 2. 9Bn. - 20th April 2020
2. Alembic Pharmaceuticals has received approval from the USFDA for a generic Adapalene gel to treat acne.. - 19th June 2020

Company Profiles

Some of the companies covered in this report are Almirall, Bausch Health Companies, Johnson & Johnson, Galderma, Mayne Pharma, Guthy-Renker. etc.

Countries Studied

  • America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas)
  • Europe (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)
  • Middle-East and Africa (Egypt, Israel, Qatar, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)
  • Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)

Competitive Quadrant

The report includes a Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Why buy this report?

  • The report offers a comprehensive evaluation of the Global Acne Drugs Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
  • The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
  • The report includes an in-depth market analysis using Porter’s 5 forces model and the Ansoff Matrix. In addition, the impact of Covid-19 on the market is also featured in the report.
  • The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
  • The report also contains the competitive analysis using Positioning Quadrants, the analyst's Proprietary competitive positioning tool.

Report Highlights:

  • A complete analysis of the market, including parent industry
  • Important market dynamics and trends
  • Market segmentation
  • Historical, current, and projected size of the market based on value and volume
  • Market shares and strategies of key players
  • Recommendations to companies for strengthening their foothold in the market
Frequently Asked Questions about the Global Acne Drugs Market

What is the estimated value of the Global Acne Drugs Market?

The Global Acne Drugs Market was estimated to be valued at $5400 Million in 2021.

What is the growth rate of the Global Acne Drugs Market?

The growth rate of the Global Acne Drugs Market is 7.1%, with an estimated value of $7600 Million by 2026.

What is the forecasted size of the Global Acne Drugs Market?

The Global Acne Drugs Market is estimated to be worth $7600 Million by 2026.

Who are the key companies in the Global Acne Drugs Market?

Key companies in the Global Acne Drugs Market include AbbVie, Akorn, Alembic Pharmaceuticals, Almirall, Bausch Health Companies, Bayer HealthCare, Cipher Pharmaceuticals, Daiichi Sankyo and Guthy.

Table of Contents

1 Report Description
1.1 Study Objectives
1.2 Market Definition
1.3 Currency
1.4 Years Considered
1.5 Language
1.6 Key Stakeholders
2 Research Methodology
2.1 Research Process
2.2 Data Collection and Validation
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Models
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Assumptions of the Study
2.5 Limitations of the Study
3 Executive Summary
3.1 Introduction
3.2 Market Size and Segmentation
3.3 Market Outlook
4 Market Influencers
4.1 Drivers
4.1.1 Increase in Prevalence of Acne
4.1.2 Unhealthy Urban Lifestyle
4.1.3 Rising Focus Facial Aesthetics
4.2 Restraints
4.2.1 Side Effects Associated with Acne Medications
4.2.2 Presence of Substitutes Acne Drug Treatment
4.3 Opportunities
4.3.1 Growing Awareness of Combination Therapy and Natural Ingredients
4.3.2 Opportunities In Emerging Economies
4.3.3 Robust Acne Medications in Pipeline
4.4 Challenges
4.4.1 Stringent Regulations for Acne Drug Approval Process
5 Market Analysis
5.1 Regulatory Scenario
5.2 Porter’s Five Forces Analysis
5.3 Impact of COVID-19
5.4 Ansoff Matrix Analysis
6 Global Acne Drugs Market, By Acne Type
6.1 Introduction
6.2 Comedonal
6.3 Inflammatory
6.4 Cystic
6.5 Postsurgical/Wound
7 Global Acne Drugs Market, By Therapeutic Class
7.1 Introduction
7.2 Retinoid
7.3 Antibiotic
7.4 Hormonal Agent
7.5 Combination
7.6 Others
8 Global Acne Drugs Market, By Drug Type
8.1 Introduction
8.2 OTC Drugs
8.3 Prescription Drugs
9 Global Acne Drugs Market, By Drug Formulation
9.1 Introduction
9.2 Topical Medications
9.3 Oral Medications
9.4 Injectable Medications
10 Global Acne Drugs Market, By Distribution Channel
10.1 Introduction
10.2 Retail Store
10.3 Pharmacy & Drug Store
10.4 E-Commerce
11 Global Acne Drugs Market, By Geography
11.1 Introduction
11.2 America
11.2.1 Argentina
11.2.2 Brazil
11.2.3 Canada
11.2.4 Chile
11.2.5 Colombia
11.2.6 Mexico
11.2.7 Peru
11.2.8 United States
11.2.9 Rest of Americas
11.3 Europe
11.3.1 Austria
11.3.2 Belgium
11.3.3 Denmark
11.3.4 Finland
11.3.5 France
11.3.6 Germany
11.3.7 Italy
11.3.8 Netherlands
11.3.9 Norway
11.3.10 Poland
11.3.11 Russia
11.3.12 Spain
11.3.13 Sweden
11.3.14 Switzerland
11.3.15 United Kingdom
11.3.16 Rest of Europe
11.4 Middle East and Africa
11.4.1 Egypt
11.4.2 Israel
11.4.3 Qatar
11.4.4 Saudi Arabia
11.4.5 South Africa
11.4.6 United Arab Emirates
11.4.7 Rest of MEA
11.5 Asia-Pacific
11.5.1 Australia
11.5.2 Bangladesh
11.5.3 China
11.5.4 India
11.5.5 Indonesia
11.5.6 Japan
11.5.7 Malaysia
11.5.8 Philippines
11.5.9 Singapore
11.5.10 South Korea
11.5.11 Sri Lanka
11.5.12 Thailand
11.5.13 Taiwan
11.5.14 Rest of Asia-Pacific
12 Competitive Landscape
12.1 Competitive Quadrant
12.2 Market Share Analysis
12.3 Strategic Initiatives
12.3.1 M&A and Investments
12.3.2 Partnerships and Collaborations
12.3.3 Product Developments and Improvements
13 Company Profiles
13.1 AbbVie
13.2 Akorn
13.3 Alembic Pharmaceuticals
13.4 Almirall
13.5 Bausch Health Companies
13.6 Bayer HealthCare
13.7 Cipher Pharmaceuticals
13.8 Daiichi Sankyo
13.9 Galderma
13.10 Guthy-Renker
13.11 Johnson & Johnson
13.12 Mayne Pharma
13.13 Nestlé Skin Health
13.14 Pfizer
13.15 Reckitt Benckiser
13.16 Roche
13.17 Skinvisible Pharmaceuticals
13.18 Stiefel (Glaxosmithkline)
13.19 Sun Pharmaceutical
13.20 Teva Pharmaceutical
13.21 Valeant Pharmaceutical
14 Appendix
14.1 Questionnaire

Companies Mentioned

  • AbbVie
  • Akorn
  • Alembic Pharmaceuticals
  • Almirall
  • Bausch Health Companies
  • Bayer HealthCare
  • Cipher Pharmaceuticals
  • Daiichi Sankyo
  • Galderma
  • Guthy-Renker
  • Johnson & Johnson
  • Mayne Pharma
  • Nestlé Skin Health
  • Pfizer
  • Reckitt Benckiser
  • Roche
  • Skinvisible Pharmaceuticals
  • Stiefel (Glaxosmithkline)
  • Sun Pharmaceutical
  • Teva Pharmaceutical
  • Valeant Pharmaceutical